Business Description
AddLife AB
ISIN : SE0014401378
Share Class Description:
ADDLF: Class BCompare
Compare
Traded in other countries / regions
ALIF B.Sweden0REZ.UK1AD1.GermanyADDLF.USA IPO Date
2018-11-27Description
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 1.06 | |||||
| Debt-to-EBITDA | 9.36 | |||||
| Interest Coverage | 1.24 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.26 | |||||
| Beneish M-Score | -2.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 19.3 | |||||
| 3-Year EBITDA Growth Rate | 14.3 | |||||
| 3-Year EPS without NRI Growth Rate | -49.7 | |||||
| 3-Year FCF Growth Rate | -20.6 | |||||
| 3-Year Book Growth Rate | 34.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 88.15 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.65 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.18 | |||||
| Quick Ratio | 0.64 | |||||
| Cash Ratio | 0.08 | |||||
| Days Inventory | 100.35 | |||||
| Days Sales Outstanding | 64.04 | |||||
| Days Payable | 57.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.7 | |||||
| Shareholder Yield % | 2 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.3 | |||||
| Operating Margin % | 4.03 | |||||
| Net Margin % | 1.17 | |||||
| FCF Margin % | 8.78 | |||||
| ROE % | 2.29 | |||||
| ROA % | 0.9 | |||||
| ROIC % | 1.4 | |||||
| ROC (Joel Greenblatt) % | 21.61 | |||||
| ROCE % | 6.57 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 141.34 | |||||
| Forward PE Ratio | 146.34 | |||||
| PE Ratio without NRI | 141.34 | |||||
| Shiller PE Ratio | 48.64 | |||||
| Price-to-Owner-Earnings | 18.74 | |||||
| PEG Ratio | 3.61 | |||||
| PS Ratio | 1.67 | |||||
| PB Ratio | 3.26 | |||||
| Price-to-Free-Cash-Flow | 19.05 | |||||
| Price-to-Operating-Cash-Flow | 19.05 | |||||
| EV-to-EBIT | 37.66 | |||||
| EV-to-EBITDA | 37.66 | |||||
| EV-to-Revenue | 2.19 | |||||
| EV-to-FCF | 24.95 | |||||
| Price-to-Projected-FCF | 1.11 | |||||
| Price-to-DCF (Earnings Based) | 20.39 | |||||
| Price-to-DCF (FCF Based) | 1.59 | |||||
| Price-to-Peter-Lynch-Fair-Value | 9.44 | |||||
| Earnings Yield (Greenblatt) % | 2.66 | |||||
| FCF Yield % | 5.25 | |||||
| Forward Rate of Return (Yacktman) % | 19.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ADDLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AddLife AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 967.55 | ||
| EPS (TTM) ($) | 0.093 | ||
| Beta | 0.05 | ||
| Volatility % | 0.11 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 42 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 42 - 42 | ||
| Shares Outstanding (Mil) | 121.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AddLife AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AddLife AB Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
AddLife AB Frequently Asked Questions
What is AddLife AB(ADDLF)'s stock price today?
The current price of ADDLF is $42.00. The 52 week high of ADDLF is $42.00 and 52 week low is $42.00.
When is next earnings date of AddLife AB(ADDLF)?
The next earnings date of AddLife AB(ADDLF) is 2025-02-05.
Does AddLife AB(ADDLF) pay dividends? If so, how much?
AddLife AB(ADDLF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers